- Home
- RCUS vs BBAI Comparison
RCUS vs BBAI Comparison
Compare RCUS & BBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- BBAI
- Stock Information
- Founded
- RCUS 2015
- BBAI 2020
- Country
- RCUS United States
- BBAI United States
- Employees
- RCUS N/A
- BBAI N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- BBAI EDP Services
- Sector
- RCUS Health Care
- BBAI Technology
- Exchange
- RCUS Nasdaq
- BBAI Nasdaq
- Market Cap
- RCUS 1.2B
- BBAI 1.1B
- IPO Year
- RCUS 2018
- BBAI N/A
- Fundamental
- Price
- RCUS $11.07
- BBAI $6.79
- Analyst Decision
- RCUS Buy
- BBAI Buy
- Analyst Count
- RCUS 11
- BBAI 4
- Target Price
- RCUS $31.11
- BBAI $4.50
- AVG Volume (30 Days)
- RCUS 1.1M
- BBAI 91.5M
- Earning Date
- RCUS 02-25-2025
- BBAI 03-06-2025
- Dividend Yield
- RCUS N/A
- BBAI N/A
- EPS Growth
- RCUS N/A
- BBAI N/A
- EPS
- RCUS N/A
- BBAI N/A
- Revenue
- RCUS $263,000,000.00
- BBAI $154,972,000.00
- Revenue This Year
- RCUS $127.65
- BBAI $13.47
- Revenue Next Year
- RCUS N/A
- BBAI $16.32
- P/E Ratio
- RCUS N/A
- BBAI N/A
- Revenue Growth
- RCUS 119.17
- BBAI 0.01
- 52 Week Low
- RCUS $10.63
- BBAI $1.17
- 52 Week High
- RCUS $20.31
- BBAI $10.36
- Technical
- Relative Strength Index (RSI)
- RCUS 34.34
- BBAI 52.65
- Support Level
- RCUS $10.63
- BBAI $7.55
- Resistance Level
- RCUS $13.49
- BBAI $10.36
- Average True Range (ATR)
- RCUS 0.77
- BBAI 1.37
- MACD
- RCUS -0.13
- BBAI -0.09
- Stochastic Oscillator
- RCUS 13.88
- BBAI 45.74
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment.